1402598-65-5

Basic information

• Product Name: N-(phenyl(7-(2-pyridinyl)-1-benzothiophen-2-yl)methyl)-3,4-dihydro-2H-1,5-benzodioxepine-7-sulfonamide
• Synonyms: N-(phenyl(7-(2-pyridinyl)-1-benzothiophen-2-yl)methyl)-3,4-dihydro-2H-1,5-benzodioxepine-7-sulfonamide
• CAS NO: 1402598-65-5
• Molecular Weight: 528.653
• Mol File: 1402598-65-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(phenyl(7-(2-pyridinyl)-1-benzothiophen-2-yl)methyl)-3,4-dihydro-2H-1,5-benzodioxepine-7-sulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(phenyl(7-(2-pyridinyl)-1-benzothiophen-2-yl)methyl)-3,4-dihydro-2H-1,5-benzodioxepine-7-sulfonamide(1402598-65-5)
• EPA Substance Registry System: N-(phenyl(7-(2-pyridinyl)-1-benzothiophen-2-yl)methyl)-3,4-dihydro-2H-1,5-benzodioxepine-7-sulfonamide(1402598-65-5)

Safety Data

• Hazardous Substances Data: 1402598-65-5(Hazardous Substances Data)

Upstream product

• 874842-53-2 3,4-dihydro-2H-1,5-benzodioxepine-7-sulfonamide 
• 1000160-74-6 2-(benzo[b]thiophen-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 109-04-6 2-bromo-pyridine 
• 100-52-7 benzaldehyde 
• 1402599-49-8 2-(1-benzothiophen-7-yl)pyridine 
• 1402599-42-1 N-(phenylmethylidene)-3,4-dihydro-2H-1,5-benzodioxepine-7-sulfonamide 

Downstream Products

• 1402598-66-6 N-((S)-phenyl(7-(2-pyridinyl)-1-benzothiophen-2-yl)methyl)-3,4-dihydro-2H-1,5-benzodioxepine-7-sulfonamide 
• 1402598-67-7 N-((R)-phenyl(7-(2-pyridinyl)-1-benzothiophen-2-yl)methyl)-3,4-dihydro-2H-1,5-benzodioxepine-7-sulfonamide 

Relevant articles and documents

BENZODIOXEPINE AND BENZODIOXINE COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES

The present invention relates to compounds of formula I or II, or pharmaceutically acceptable salts thereof, that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.